Keyron appoints new Chief Executive Officer

LONDON, Feb. 07, 2023 (GLOBE NEWSWIRE) — Today Keyron, the medical technology group focused on reversing type 2 diabetes, non–alcoholic steatohepatitis (NASH), and obesity via an innovative medical device platform, announced [...] Read more »